@FiercePharma: Top-read story this weekend: Novartis fighting two-pronged legal battle in India on Galvus patent. Story | Follow @FiercePharma
@TracyStaton: FiercePharma's best-read marketing story: Sanofi aims for outcomes with new Chief Patient Officer. Article | Follow @TracyStaton
@EricPFierce: Daiichi Sankyo hinted months ago it was tired of Ranbaxy's issues. Buyout means Sun Pharma takes them on. More | Follow @EricPFierce
@CarlyHFierce: Novartis meningitis B vaccine Bexsero receives FDA breakthrough therapy designation in the U.S. Release | Follow @CarlyHFierce
> Gilead Sciences ($GILD) won a "breakthrough" designation from the FDA for its hepatitis C combo pill, putting it in line for U.S. approval by October 10. Report
> IMS Health Holdings ($IMS) priced its initial public offering at $20 per share to raise $1.3 billion. Report (sub. req.)
> Roche ($RHHBY) snapped up a medical testing equipment maker, IQuum, for up to $450 million. Report
> GlaxoSmithKline's ($GSK) Asia unit pulled its over-the-counter painkiller Crocin Advance after Indian officials ordered it to stop selling the drug because it was overcharging for it. Report
> Specialty pharmacy Diplomat signed up with Celgene ($CELG) to distribute the company's brand new psoriatic arthritis treatment Otezla in the U.S. Report
> A U.S. judge sentenced a South Florida "pill mill" doctor to more than 6 years in prison for money-laundering, in a case related to thousands of painkiller prescriptions she wrote. Report
@FierceMedDev: CyVek immunoassay technology gets $10M investment. Story | Follow @FierceMedDev
@VarunSaxena2: ICYMI: After a successful IPO, LDR looks to raise more cash. News | Follow @VarunSaxena2
@MichaelGFierce: DNA nanorobot delivers drugs through flap that opens and closes. More from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Motorized, sensor-driven wheelchair could provide a new level of mobility for those with severe disabilities. Article | Follow @EmilyWFierce
> Edwards Lifesciences wins CE mark for aortic valve system. More
> Roche snags diagnostics outfit IQuum in $450M deal. Story
> Medtronic buys out a distributor as it cozies up to Turkey. News
Biotech News
@FierceBiotech: Little Deciphera raises its cancer R&D flag in Boston's bustling biotech hub. More | Follow @FierceBiotech
@JohnCFierce: Agios shares spike on enthusiastic response to small, early-stage leukemia study. Story | Follow @JohnCFierce
@DamianFierce: Here's FierceBiotech's look at every drug developer IPO from the first quarter. Report | Follow @DamianFierce
@EmilyMFierce: 40% of the world's population is at risk from dengue. More in WHO's report for World Health Day. Report | Follow @EmilyMFierce
CRO News
> Clinipace signs up to get a brain-stimulating device on the U.S. market. Article
> WuXi bets on anti-counterfeiting tech with an eye on drug safety. More
> Actavis picks Particle Sciences for generics development. Story
> AMRI expects its $41M Cedarburg deal to pay off right away. News
> Evotec lands two more deals to share risks and rewards of R&D. Report
> Charles River wraps up $179M deal for Galapagos' CRO biz. Item
Biotech IT News
> Merck KGaA and Pfizer tap into Broad Institute's data skills for lupus project. Story
> Tufts survey shows social media still on fringes of clinical trials. More
> Billionaire-backed startup puts Big Data, AI at the heart of drug discovery. News
> Merck vaccine plant taps R&D's Big Data platform to solve yield conundrum. Article
> IMS Health stock jumps after second biggest U.S. IPO of 2014. Item
> Europe to create public clinical trial results database after passing law. Report
And Finally... Most states are secretive about their execution drugs, a policy that's under increasing legal attack. Report